🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this project is to characterise the heterogeneity of all cell p...
Status
Not Yet Recruiting
Location
Centre Léon Bérard
Start Date
2026-06
Trial ID
NCT07579507
Treatments Being Tested
This study is a dynamically adjustable prospective longitudinal study desig...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-01-11
Trial ID
NCT05975593
The study is aimed to determine the potential of volatile marker testing fo...
Status
Recruiting
Location
A.C.Camargo Cancer Center
Start Date
2019-11-01
Trial ID
NCT04022109
Cervical cancer is the most common cause of cancer and a leading cause of d...
Status
Unknown
Location
HIV day care center
Start Date
2019-03-01
Trial ID
NCT03789513
Treatments Being Tested
This is a single-site, single-arm, prospective, interventional cohort study...
Status
Not Yet Recruiting
Location
NYU Langone Health
Start Date
2025-12
Trial ID
NCT07219199
Treatments Being Tested
This phase III trial compares the effect of sentinel lymph node mapping to ...
Status
Recruiting
Location
George Washington University Medical Center
Start Date
2022-12-07
Trial ID
NCT05646316
This phase II trial studies the side effects of talimogene laherparepvec an...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2019-12-31
Trial ID
NCT02923778
RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11
Trial ID
NCT00423865
This research trial studies genetic profiles in blood and tumor samples fro...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2017-11-13
Trial ID
NCT03281902
Treatments Being Tested
To analyze the metabolic activity of Hormone Receptor Positive (HR+)/Her 2 ...
Status
Recruiting
Location
Rutgers Cancer Institute of New Jersey
Start Date
2024-11-15
Trial ID
NCT05736367
Treatments Being Tested